Evoce Capital
InvestorActiveEvoce Capital is a venture capital firm founded in 2024 that provides pre-institutional funding to US-based, founder-led companies. The firm deploys initial checks of $150K–$2M from seed through Series A, using SAFE instruments, convertible notes, or priced rounds. It is explicitly industry-agnostic, investing across all sectors and regulatory environments, including healthcare, fintech, life sciences, and beyond, with a stated preference for technically strong founding teams. The firm's team includes Managing Partner & CEO Katie Price, Partner & CFO Preston Davis, and Partner Nicole Price (a geoscientist with experience across DOD and EPA-regulated fields), supported by serial-entrepreneur advisors. Portfolio companies to date include Beanstack (EdTech) and Senticell (life sciences/liquid biopsy). Evoce Capital offers founders access to a network of entrepreneurs with experience building public companies and transforming enterprises in regulated industries.
Founder Intel
Sign in to read intel from founders who have worked with Evoce Capital.
What founders say about Evoce Capital
Be the first to share intel on Evoce Capital — it's free.
Get Started FreeRelated on The List
- ACF Investors — Investor · Sheffield, United Kingdom
- Aglaé Ventures — Investor · Paris, France
- Aleph — Investor · Tel Aviv, Israel
- BGF — Investor · London, UK
- Blossom Capital — Investor · London, United Kingdom
Comparing options? Founders discuss fundraising in the forum, or browse the rest of The List.